SEC Form 4 · accession 0001127430-18-000050

INSMED Inc · INSM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief People Strategy Officer

Period of report

May 29, 2018

Accepted (ET)

May 31, 2018 · 4:05 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001104506

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	May 29, 2018	M	11,584	$10.85	A	22,253	D
Common Stock^F1	May 29, 2018	S	11,584	$27.68	D	10,669	D
Common Stock	May 30, 2018	M	25,991	$10.85	A	36,660	D
Common Stock^F2	May 30, 2018	S	25,991	$28.24	D	10,669	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F3	$10.85	May 29, 2018	M	11,584	D	—	May 19, 2026	Common Stock	11,584	63,566	D
Stock Option (right to buy)^F3	$10.85	May 30, 2018	M	25,991	D	—	May 19, 2026	Common Stock	25,991	37,575	D

F1This is the weighted average sales price representing 11,584 shares sold at prices ranging from $27.60 to $27.84 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
F2This is the weighted average sales price representing 25,991 shares sold at prices ranging from $28.00 to $28.32 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
F3Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one-half percent (12.5%) vest on the six month anniversary of the first anniversary date and each six month anniversary date thereafter through the fourth anniversary of the date of grant.